PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358086
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358086
General Anesthesia Drugs Market, By Drug molecule, By Route of Administration, By End User, By Geography
The global general anesthesia drug market is estimated to be valued at US$ 4.95 Billion in 2023 and is expected to exhibit a CAGR of 4.1% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 4.95 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 4.10% | 2030 Value Projection: | US$ 6.57 Bn |
General anesthesia drugs are meant to manifest unconscious patient by the inhibition of sensory, motor, and sympathetic nerve transmission at the level of the brain that results in unconsciousness and lack of sensation and incapable to feel painful stimuli while controlling involuntary reflexes. General anesthesia drugs are administrated by two routes either by intravenous anesthetics that includes drug molecules like propofol, etomidate, methohexital, thiopentone, midazolam and ketamine and other is inhalation anesthetics that includes drug molecules like desflurane, isoflurane, and sevoflurane. The key players are primarily focusing on modifying the chemical structures of existing drugs or drug classes with a direction to improve their pharmacokinetic, pharmacodynamics, and side effect properties. Furthermore, they are developing drugs that have possibilities of using Target Controlled Infusion (TCI). The new applications of pre-existing anesthetic drugs are being explored. Thus, the introduction of such drugs with lesser side effects and target controlled infusion in the market are expected to drive the growth of the global general anesthesia drugs market over the forecast period.
Market Dynamics
The key players in the pharmacology industry are focusing on the development of drugs with lesser side effects by the modification of preexisting drugs. For instance, in July 2022, Cosmo pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved BYFAVO (Remimazolam), a novel benzodiazepine for intravenous anesthetics approved for use as procedural sedation and general anesthesia. It has an ultra-short duration of action and it uses target controlled infusion with short and expected duration of sedative action, short recovery time, rare accumulation after long-term infusion, and lesser side effects as compared to those of other currently used Benzodiazepines molecule of general anesthesia drugs. Thus, the introduction of such drugs with lesser side effects in the market is expected offer opportunities for drug manufacturers to develop more novel drugs with lesser side effects.
Key features of the study:
- This report provides an in-depth analysis of the global general anesthetic drug market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global general anesthetic drug market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius Kabi, Pfizer Inc., Hikma Pharmaceuticals, Sagent Pharmaceuticals, Teva Pharmaceuticals, Par Pharmaceutical, Viatris Inc., AbbVie, Piramal Critical Care, Aspen Global Incorporated, B. Braun SE, Abbott, COSMO PHARMACEUTICALS, Hospira Inc., Maruishi, Hengrui, and Lunan
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global general anesthetic drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global general anesthetic drug market.
Detailed Segmentation:
- Global General Anesthesia Drugs Market, By Drug molecule:
- Desflurane
- Isoflurane
- Sevoflurane
- Propofol
- Etomidate
- Methohexital
- Thiopentone
- Midazolam
- Ketamine
- Global General Anesthesia Drugs Market, By Route of Administration:
- Intravenous Anesthesia
- Inhalation Anesthesia
- Global General Anesthesia Drugs Market, By End User:
- Hospital
- Specialty Clinics
- Ambulatory Surgical Centers
- Global General Anesthesia Drugs Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Baxter Healthcare
- Dr. Reddy's Laboratories
- Novartis International AG
- Hospira
- Maruishi
- Hengrui
- Lunan
- Fresenius Kabi
- Pfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- Cosmo pharmaceuticals
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Molecule
- Market Snippet, By Route of Administration
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Development
- Pipeline Analysis
- Distribution Channel Analysis
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global General Anesthesia Drug Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global General Anesthesia Drug Market , By Drug Molecule, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Propofol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Etomidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Etomidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Thiopentone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Midazolam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
6. Global General Anesthesia Drug Market , By Route of Administration, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Intravenous Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Inhalation Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
7. Global General Anesthesia Drug Market , By End User, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
8. Global General Anesthesia Drug Market , By Region, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Baxter Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Reddy's Laboratories
- Novartis International AG
- Hospira
- Maruishi
- Hengrui
- Lunan
- Fresenius Kabi
- Pfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- Cosmo pharmaceuticals
10. Section
- References
- Research Methodology
- About us and Sales Contact
